Nantong Jinghua Pharmaceutical Co Ltd
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and… Read more
Nantong Jinghua Pharmaceutical Co Ltd (002349) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.032x
Based on the latest financial reports, Nantong Jinghua Pharmaceutical Co Ltd (002349) has a cash flow conversion efficiency ratio of 0.032x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥97.93 Million) by net assets (CN¥3.09 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nantong Jinghua Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Nantong Jinghua Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Nantong Jinghua Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nantong Jinghua Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SALCEF GROUP S.P.A.
F:7S9
|
N/A |
|
Paradox Interactive AB (publ)
PINK:PRXXF
|
0.205x |
|
Shenyang Jinbei Automotive Co Ltd
SHG:600609
|
0.204x |
|
Sdiptech AB
LSE:0AAV
|
N/A |
|
Jinchuan Group International Resources Co. Ltd
PINK:JGRRF
|
N/A |
|
Arteris Inc
NASDAQ:AIP
|
-0.217x |
|
ITMAX System Berhad
KLSE:5309
|
0.184x |
|
Hangzhou EZVIZ Network Co. Ltd. A
SHG:688475
|
N/A |
Annual Cash Flow Conversion Efficiency for Nantong Jinghua Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.96 Billion | CN¥311.02 Million | 0.105x | +1.25% |
| 2023-12-31 | CN¥2.80 Billion | CN¥291.31 Million | 0.104x | -23.95% |
| 2022-12-31 | CN¥2.62 Billion | CN¥358.39 Million | 0.137x | +14.86% |
| 2021-12-31 | CN¥2.57 Billion | CN¥305.57 Million | 0.119x | -9.90% |
| 2020-12-31 | CN¥2.49 Billion | CN¥328.22 Million | 0.132x | -0.67% |
| 2019-12-31 | CN¥2.15 Billion | CN¥285.38 Million | 0.133x | +329.14% |
| 2018-12-31 | CN¥2.69 Billion | CN¥83.43 Million | 0.031x | +7.96% |
| 2017-12-31 | CN¥2.65 Billion | CN¥75.92 Million | 0.029x | -80.79% |
| 2016-12-31 | CN¥2.30 Billion | CN¥343.80 Million | 0.149x | +538.78% |
| 2015-12-31 | CN¥2.23 Billion | CN¥-76.01 Million | -0.034x | -214.26% |
| 2014-12-31 | CN¥1.53 Billion | CN¥45.70 Million | 0.030x | +140.21% |
| 2013-12-31 | CN¥741.83 Million | CN¥-54.94 Million | -0.074x | -168.54% |
| 2012-12-31 | CN¥714.87 Million | CN¥77.25 Million | 0.108x | +65.90% |
| 2011-12-31 | CN¥636.30 Million | CN¥41.45 Million | 0.065x | -13.63% |
| 2010-12-31 | CN¥544.45 Million | CN¥41.06 Million | 0.075x | -82.10% |
| 2009-12-31 | CN¥137.11 Million | CN¥57.76 Million | 0.421x | +191.81% |
| 2008-12-31 | CN¥118.66 Million | CN¥17.13 Million | 0.144x | -60.84% |
| 2007-12-31 | CN¥91.86 Million | CN¥33.86 Million | 0.369x | +16.34% |
| 2006-12-31 | CN¥70.00 Million | CN¥22.18 Million | 0.317x | -- |